Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between <scp>MK</scp> ‐1293 insulin glargine and originator insulin glargine ( <scp>L</scp> antus) in subjects with type 1 diabetes and healthy subjects

Abstract

Based on comparative assessment in both T1D and healthy subjects, it can be concluded that the PK and PD properties of MK-1293 are highly similar to those of Lantus. (ClinicalTrials.gov: NCT02059174).